ERIN HAGEN: Open Payments
NPI 1285300475 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 6 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $247 |
| Galderma Laboratories, L.P. | 1 | $150 |
| Organon LLC | 1 | $139 |
| Lilly USA, LLC | 1 | $118 |
| UCB, Inc. | 1 | $113 |
Products named: TREMFYA, NEMLUVIO, VTAMA, EBGLYSS, Bimzelx.
Industry payments across OR — which companies pay providers there.
